Dimaprit dihydrochloride

CAS No. 23256-33-9

Dimaprit dihydrochloride ( —— )

Catalog No. M24062 CAS No. 23256-33-9

Dimaprit dihydrochloride is a selective histamine H2 receptor agonist. Dimaprit dihydrochloride also inhibits nNOS with an IC50 of 49 μM. It can stimulate gastric acid secretion.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
25MG 43 In Stock
50MG 74 In Stock
100MG 119 In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    Dimaprit dihydrochloride
  • Note
    Research use only, not for human use.
  • Brief Description
    Dimaprit dihydrochloride is a selective histamine H2 receptor agonist. Dimaprit dihydrochloride also inhibits nNOS with an IC50 of 49 μM. It can stimulate gastric acid secretion.
  • Description
    Dimaprit dihydrochloride is a selective histamine H2 receptor agonist. Dimaprit dihydrochloride also inhibits nNOS with an IC50 of 49 μM. It can stimulate gastric acid secretion.
  • Synonyms
    ——
  • Pathway
    GPCR/G Protein
  • Target
    Histamine Receptor
  • Recptor
    H2 receptor;nNOS
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    23256-33-9
  • Formula Weight
    234.2
  • Molecular Formula
    C6H15N3S·2HCl
  • Purity
    >98% (HPLC)
  • Solubility
    H2O:<23.42mg/ml
  • SMILES
    NC(SCCCN(C)C)=N.[H]Cl.[H]Cl
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Parsons ME, et, al. Dimaprit -(S-[3-(N,N-dimethylamino)prophyl]isothiourea) - a highly specific histamine H2 -receptor agonist. Part 1. Pharmacology. Agents Actions. 1977 Mar; 7(1): 31-7.
molnova catalog
related products
  • LY2624803

    LY2624803 is a novel potent histamine H1 and 5HT-2A receptor modulator in the pipeline for treating insomnia.

  • JNJ-18038683

    JNJ-18038683 is a potent, selective 5-HT7 receptor antagonist with pKi of 8.19 and 8.20 for rat and human 5-HT7 in cell-based assays; decreases 5-HT (100 nM)-stimulated adenylyl cyclase in rat and human 5-HT7/HEK293 cells with pKb of 8.01 and 7.99, respectively.

  • Astemizole

    Antihistamine drug now withdrawn from the market in many countries because of rare but potentially fatal side effects.